Aminoglycoside-induced histone deacetylation and hair cell death in the mouse cochlea
dc.contributor.author | Chen, Fu-Quan | en_US |
dc.contributor.author | Schacht, Jochen | en_US |
dc.contributor.author | Sha, Su-Hua | en_US |
dc.date.accessioned | 2010-04-01T15:47:29Z | |
dc.date.available | 2010-04-01T15:47:29Z | |
dc.date.issued | 2009-03 | en_US |
dc.identifier.citation | Chen, Fu-Quan; Schacht, Jochen; Sha, Su-Hua (2009). "Aminoglycoside-induced histone deacetylation and hair cell death in the mouse cochlea." Journal of Neurochemistry 108(5): 1226-1236. <http://hdl.handle.net/2027.42/66284> | en_US |
dc.identifier.issn | 0022-3042 | en_US |
dc.identifier.issn | 1471-4159 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/66284 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=19141081&dopt=citation | en_US |
dc.format.extent | 1650648 bytes | |
dc.format.extent | 3110 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | Journal compilation © 2009 International Society for Neurochemistry | en_US |
dc.subject.other | Cochlear Explant | en_US |
dc.subject.other | Gentamicin | en_US |
dc.subject.other | Histone Acetyl Transferase | en_US |
dc.subject.other | Histone Deacetylase Inhibitors | en_US |
dc.subject.other | Ototoxicity | en_US |
dc.title | Aminoglycoside-induced histone deacetylation and hair cell death in the mouse cochlea | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.identifier.pmid | 19141081 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/66284/1/j.1471-4159.2009.05871.x.pdf | |
dc.identifier.doi | 10.1111/j.1471-4159.2009.05871.x | en_US |
dc.identifier.source | Journal of Neurochemistry | en_US |
dc.identifier.citedreference | Bhaumik S. R., Smith E. and Shilatifard A. ( 2007 ) Covalent modifications of histones during development and disease pathogenesis. Nat. Struct. Mol. Biol. 14, 1008 – 1016. | en_US |
dc.identifier.citedreference | Dashwood R. H. and Ho E. ( 2007 ) Dietary histone deacetylase inhibitors: from cells to mice to man. Semin. Cancer Biol. 17, 363 – 369. | en_US |
dc.identifier.citedreference | Ding D., Stracher A. and Salvi R. J. ( 2002 ) Leupeptin protects cochlear and vestibular hair cells from gentamicin ototoxicity. Hear. Res. 164, 115 – 126. | en_US |
dc.identifier.citedreference | Drottar M., Liberman M. C., Ratan R. R. and Roberson D. W. ( 2006 ) The histone deacetylase inhibitor sodium butyrate protects against cisplatin-induced hearing loss in guinea pigs. Laryngoscope 116, 292 – 296. | en_US |
dc.identifier.citedreference | Elaut G., Laus G., Alexandre E., Richert L., Bachellier P., Tourwe D., Rogiers V. and Vanhaecke T. ( 2007 ) A metabolic screening study of trichostatin A (TSA) and TSA-like histone deacetylase inhibitors in rat and human primary hepatocyte cultures. J. Pharmacol. Exp. Ther. 321, 400 – 408. | en_US |
dc.identifier.citedreference | Fischer A., Sananbenesi F., Wang X., Dobbin M. and Tsai L. H. ( 2007 ) Recovery of learning and memory is associated with chromatin remodelling. Nature 447, 178 – 182. | en_US |
dc.identifier.citedreference | Forge A. and Schacht J. ( 2000 ) Aminoglycoside antibiotics. Audiol. Neurootol. 5, 3 – 22. | en_US |
dc.identifier.citedreference | Gao L., Cueto M. A., Asselbergs F. and Atadja P. ( 2002 ) Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family. J. Biol. Chem. 277, 25748 – 25755. | en_US |
dc.identifier.citedreference | Glaser K. B. ( 2007 ) HDAC inhibitors: clinical update and mechanism-based potential. Biochem. Pharmacol. 74, 659 – 671. | en_US |
dc.identifier.citedreference | Hainrichson M., Nudelman I. and Baasvo T. ( 2008 ) Designer aminoglycosides: the race to develop improved antibiotics and compounds for the treatment of human genetic diseases. Org. Biomol. Chem. 21, 227 – 239. | en_US |
dc.identifier.citedreference | Hermann C. ( 2007 ) Review: variability of host-pathogen interaction. J. Endotoxin Res. 13, 199 – 218. | en_US |
dc.identifier.citedreference | Jiang H., Sha S.-H. and Schacht J. ( 2005 ) The NF-κB pathway protects cochlear hair cells from aminoglycoside-induced ototoxicity. J. Neurosci. Res. 79, 644 – 651. | en_US |
dc.identifier.citedreference | Jiang H., Sha S. H. and Schacht J. ( 2006a ) Kanamycin alters cytoplasmic and nuclear phosphoinositide signaling in the organ of Corti in vivo. J. Neurochem. 99, 269 – 276. | en_US |
dc.identifier.citedreference | Jiang H., Sha S. H., Forge A. and Schacht J. ( 2006b ) Caspase-independent pathways of hair cell death induced by kanamycin in vivo. Cell Death Differ. 13, 20 – 30. | en_US |
dc.identifier.citedreference | Kawaguchi Y., Kovacs J. J., McLaurin A., Vance J. M., Ito A. and Yao T. P. ( 2003 ) The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell 115, 727 – 738. | en_US |
dc.identifier.citedreference | Kim H. J., Rowe M., Ren M., Hong J. S., Chen P. S. and Chuang D. M. ( 2007 ) Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. J. Pharmacol. Exp. Ther. 321, 892 – 901. | en_US |
dc.identifier.citedreference | Lu Q., Qiu X., Hu N., Wen H., Su Y. and Richardson B. C. ( 2006 ) Epigenetics, disease, and therapeutic interventions. Ageing Res. Rev. 5, 449 – 467. | en_US |
dc.identifier.citedreference | Marks P. A., Richon V. M., Breslow R. and Rifkind R. A. ( 2001 ) Histone deacetylase inhibitors as new cancer drugs. Curr. Opin. Oncol. 13, 477 – 483. | en_US |
dc.identifier.citedreference | Marks P. A., Richon V. M., Miller T. and Kelly W. K. ( 2004 ) Histone deacetylase inhibitors. Adv. Cancer Res. 91, 137 – 168. | en_US |
dc.identifier.citedreference | Morrison B. E., Majdzadeh N., Zhang X., Lyles A., Bassel-Duby R., Olson E. N. and D’Mello S. R. ( 2006 ) Neuroprotection by histone deacetylase-related protein. Mol. Cell. Biol. 26, 3550 – 3564. | en_US |
dc.identifier.citedreference | Myrdal S. E., Johnson K. C. and Steyger P. S. ( 2005 ) Cytoplasmic and intra-nuclear binding of gentamicin does not require endocytosis. Hear. Res. 204, 156 – 169. | en_US |
dc.identifier.citedreference | de Ruijter A. J., van Gennip A. H., Caron H. N., Kemp S. and van Kuilenburg A. B. ( 2003 ) Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem. J. 370, 737 – 749. | en_US |
dc.identifier.citedreference | Sadri-Vakili G. and Cha J. H. ( 2006 ) Mechanisms of disease: histone modifications in Huntington’s disease. Nat. Clin. Pract. Neurol. 2, 330 – 338. | en_US |
dc.identifier.citedreference | Saha R. N. and Pahan K. ( 2006 ) HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis. Cell Death Differ. 13, 539 – 550. | en_US |
dc.identifier.citedreference | Sha S.-H. and Schacht J. ( 1998 ) Are aminoglycoside antibiotics excitotoxic? Neuroreport 9, 3893 – 3895. | en_US |
dc.identifier.citedreference | Sha S.-H., Taylor R., Forge A. and Schacht J. ( 2001 ) Differential vulnerability of basal and apical hair cells is based on intrinsic susceptibility to free radicals. Hear. Res. 155, 1 – 8. | en_US |
dc.identifier.citedreference | Siavoshian S., Segain J. P., Kornprobst M., Bonnet C., Cherbut C., Galmiche J. P. and Blottiere H. M. ( 2000 ) Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression. Gut 46, 507 – 514. | en_US |
dc.identifier.citedreference | Tabuchi K., Pak K., Chavez E. and Ryan A. F. ( 2007 ) Role of inhibitor of apoptosis protein in gentamicin-induced cochlear hair cell damage. Neuroscience 149, 213 – 222. | en_US |
dc.identifier.citedreference | Taylor J. P. and Fischbeck K. H. ( 2002 ) Altered acetylation in polyglutamine disease: an opportunity for therapeutic intervention? Trends Mol. Med. 8, 195 – 197. | en_US |
dc.identifier.citedreference | Wu W. J., Sha S. H., McLaren J. D., Kawamoto K., Raphael Y. and Schacht J. ( 2001 ) Aminoglycoside ototoxicity in adult CBA, C57BL and BALB mice and the Sprague-Dawley rat. Hear. Res. 158, 165 – 178. | en_US |
dc.identifier.citedreference | Xu W. S., Parmigiani R. B. and Marks P. A. ( 2007 ) Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene 26, 5541 – 5552. | en_US |
dc.identifier.citedreference | Zhang M., Liu W., Ding D. and Salvi R. ( 2003 ) Pifithrin-alpha suppresses p53 and protects cochlear and vestibular hair cells from cisplatin-induced apoptosis. Neuroscience 120, 191 – 205. | en_US |
dc.identifier.citedreference | Zheng J. L. and Gao L. ( 1996 ) Differential damage to auditory neurons and hair cells by ototoxins and neuroprotection by specific neurotrophins in rat cochlear organotypic cultures. Eur. J. Neurosci. 8, 1897 – 1905. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.